Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy
.
Source: Infectious Diseases - Category: Infectious Diseases Authors: Pilar Vizcarra Jos é L. Blanco Roc ío Montejano Eugenia Negredo Nuria Espinosa Jos é L. Casado Source Type: research
More News: Infectious Diseases | Prezista